acarbose vs insulin aspart
Side-by-side comparison of acarbose and insulin aspart Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Precose
NovoLog, Fiasp
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
NovoLog (insulin aspart) is a rapid-acting insulin that helps control blood sugar in people with diabetes. It works quickly to lower blood sugar levels after meals.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
NovoLog is used to improve blood sugar control in adults and children with diabetes. Diabetes is a condition where your body doesn't make enough insulin or can't use insulin properly, leading to high blood sugar. This medicine helps to lower your blood sugar levels.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
NovoLog is a man-made form of insulin that works like the insulin your body naturally makes. It helps sugar (glucose) move from your blood into your cells, where it can be used for energy. This lowers the amount of sugar in your blood.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Headache
- • Accidental injury
- • Nausea
- • Diarrhea
- • Low blood sugar
- Low blood sugar 269
- Feeling sick to your stomach 203
- High blood sugar 200
- Feeling lightheaded 160
- Loose, watery stools 147
- High blood sugar 10,423
- Feeling sick to your stomach 3,724
- Low blood sugar 3,343
- The medicine is not working 3,287
- Feeling tired 2,663
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
Never share your NovoLog FlexPen, FlexTouch, PenFill cartridge, or PenFill cartridge device with anyone else, even if the needle is changed. Sharing insulin pens or cartridges can spread blood-borne diseases. Changes in your insulin regimen should be made carefully under medical supervision. Low blood sugar can be life-threatening. Monitor your blood sugar regularly. Fluid retention and heart failure can occur if you take NovoLog with thiazolidinediones (TZDs).
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Discuss the best way to manage your blood sugar with your doctor.
Also Compare — Nearby Drugs
Compare acarbose with
Compare insulin aspart with
How to Read This acarbose vs insulin aspart Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while insulin aspart sits within the Rapid-Acting Insulin class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while insulin aspart has 23,440. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acarbose and insulin aspart — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.